Background: Migraine is a prevalent and incapacitating condition that affects individuals in the prime of their productive life, thus generating an economic burden for both society and healthcare systems. The direct annual healthcare costs of migraine in France were assessed over 10 years ago,...

Migraine is a highly prevalent, chronic, episodic condition. The direct and indirect costs of migraine have a large economic impact. Research has shown that migraine abortive medications reduce healthcare costs, improve health-related quality of life, decrease migraine disability and keep...

Background: The Disability in Strategies for Care (DISC) study was the first large randomised controlled trial to compare alternative treatment strategies in the acute treatment of migraine. With 835 patients in its intention-to-treat efficacy analysis, DISC compared a stratified care strategy,...

Objective: To examine the cost effectivess of a stratified-care regimen for patients with migraine - in which patients are stratified by severity of illness, and then prescribed differing treatments according to level of severity - compared with a conventional stepped-care approach. Design and...

Objective: To compare self-reported healthcare resource utilisation, paid work loss, unpaid work loss and loss of effectiveness at work due to migraine in a clinic-based adult migraine population. Methods: The Migraine Background Questionnaire(C) (MBQ) was translated and pilot-tested for use in...

Migraine is a highly prevalent, nonfatal disorder typically characterized by recurrent episodes of headache associated with such symptoms as nausea, vomiting, photophobia, phonophobia and impaired functioning. The attacks may be infrequent and relatively mild; more often they are frequent, severe...

There is abundant evidence for the incapacity and reduction in quality of life experienced by individuals with migraine and also for a somewhat unsympathetic attitude from the 80% or so of the population who do not experience recurrent incapacitating headaches. The burden of migraine is reviewed...

Objective: To calculate and compare the human capital approach (HCA) and friction cost approach (FCA) methods for estimating the cost of lost productivity of migraineurs after the initiation of sumatriptan from a US societal perspective. Design: Secondary, retrospective analysis to a prospective...

Background: The growing literature on the economics of migraine and its treatment generally indicates that the direct healthcare costs of managing the disorder are relatively low compared with the personal and societal burdens resulting from the disruption to normal functioning caused by...

Migraine is a common chronic headache disorder affecting more than 10% of persons in Western populations. The clinical management of migraine is notable for the variability of diagnostic testing, therapeutic interventions and cost. Standards of care and clinical guidelines for migraine have...